DIA: Driving Insights to Action

Jan 17 2025 20 ep. 16 mins 1.3k
DIA: Driving Insights to Action Podcast artwork

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

  Science  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


DIA/Tufts CSDD Research: AI Saving Time in Drug Development

Jan 17 2025 11 mins  
DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, conducted a study to map current use of and experience with artificial intelligence (AI) and machine learning (ML), and their ability to reduce time across activities, in the drug development lifecycle. “We benchmarked various applications of AI

DIA: Your Partner in Life Sciences Training and Development

Nov 06 2024 14 mins  
This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs for employees in the life sciences industry. They emphasizes how training and development initiatives accelerate product development, improve employee retention, and foster a strong workplace culture. It showcases DIA’s commitment to providi

DIA: Going Beyond the Traditional Definition of Drug Development

May 29 2024 1 mins  
In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future for the next generation of members.

GPP Experts Explain Authorship Algorithm

Apr 23 2024 7 mins  
Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other authors' contributions in a study, and to define appropriate ways to establish the authorship byline.

"Dossier in the Cloud" Democratizing Global Access

Apr 02 2024 2 mins  
Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes the Accumulus platform and follows WHO principles of good regulatory reliance practices.

DIA: A Place Where You Can Make a Difference

Mar 28 2024 1 mins  
Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2024.

Autumn’s Leukemia Story: Regimens, Recovery, and Realizations

Dec 04 2023 19 mins  
A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a new chapter not only in Autumn’s life but in the life of her entire family: Autumn had leukemia. In this interview, Autumn shares the story of her treatment and recovery as a girl who had not yet turned 11. Her experience was also captured in

Retiring TGA Head Maps Australia’s Post-Pandemic Future

Jul 17 2023 18 mins  
In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulation Group and head of the Therapeutic Goods Administration in Australia. “What's really changed and what will persist after COVID? First, I think regulators have become a bit more comfortable in dealing with uncertainty. Uncertainty is the bi

Patient Engagement: Evolution of Who Knows What, Part 2

Jun 14 2023 14 mins  
In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in the future of patient engagement in clinical research and care with DIA GAM 2023 Patient Engagement track chair Pujita Vaidya. “This advent and acceleration of artificial intelligence (which should be augmented intelligence) and digital b

Patient Engagement: Evolution of Who Knows What, Part 1

Jun 12 2023 18 mins  
DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clinical research and care with cancer survivors and “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel). “Many people were trained for generations to think of patients as poor people who just don't understand ho